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BACKGROUND: Recent research has shown that most of the excess risk of death following breast and colorectal cancer in England
compared with Norway and Sweden occurs in older age groups during the first year, and especially in the first month of follow-up.
The aim of this study was to explore the characteristics of patients dying within 30 days of being diagnosed with one of these cancers
in Scotland during 2003–2007.
METHODS: Anonymised cancer registry records linked to hospital discharge and death records were extracted. The study population
was divided into patients who died within 30 days of diagnosis (cases) and those who survived beyond this threshold (controls).
Differences in patient-, tumour-, and health service-related characteristics were assessed using the w
2-test and logistic regression.
RESULTS: Patients dying within 30 days were more likely to be elderly and to have experienced emergency admission to non-surgical
specialities. Their tumours were less likely to have been verified microscopically, but they appeared more likely to be of high grade
and advanced in stage. A substantial number of patients died from causes other than their cancer.
CONCLUSION: These results suggest that early mortality after a diagnosis of breast or colorectal cancer may be partly due to
comorbidity and lifestyle factors, as well as due to more advanced disease. Further research is required to determine the precise
explanation for these findings and, in particular, if any potentially avoidable factors such as delays in presentation, referral, or diagnosis
exist.
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Survival from major epithelial cancers appears to be lower in the
United Kingdom than in the Nordic countries, with the interesting
exception of Denmark (Sant et al, 2009). More detailed analyses
suggest that most of the excess risk of mortality in the United
Kingdom compared with the Nordic countries occurs within a year
of diagnosis (Engholm et al, 2007; Thomson and Forman, 2009;
Holmberg et al, 2010) and particularly within a month of diagnosis
in older patients with breast cancer (Møller et al, 2010) or
colorectal cancer (H Møller, personal communication). A popular
interpretation, which underpins the National Awareness and Early
Diagnosis Initiative in England (Department of Health, 2007), is
that delays in presentation and/or referral, resulting in more
advanced disease stage at diagnosis, are responsible for much of
the survival deficit observed in patients with cancer in the United
Kingdom. However, there are alternative explanations for the
excess risk of early death. These include the following: increased
comorbidity leading to increased operative risks; smoking, obesity,
alcohol abuse, and other factors related to lifestyle, which might
both increase surgical risks and limit options for non-surgical
therapies; and socioeconomic deprivation, which has been
associated with increased risk of early death, although the
mediators of any such effect are undoubtedly complex.
The aim of this study was to examine the characteristics of
patients with breast or colorectal cancer who die within 30 days of
diagnosis, using health service data collected routinely and, using
proxy indicators, to explore the influence of socioeconomic
deprivation, co-morbidity, and lifestyle on outcome.
MATERIALS AND METHODS
Anonymised records relating to patients diagnosed with breast
cancer (ICD-10 C50) or colorectal cancer (C18-C20) during the
period 2003–2007 were extracted from the Scottish Cancer
Registry (SCR). Patients registered on the basis of a death
certificate only were excluded (o1% of cases for both cancer
sites). Only the first breast or colorectal cancer arising in an
individual was included in the analysis.
Patient-, tumour-, and health service-related variables from the
SCR were supplemented with variables derived from a perma-
nently linked database of acute hospital discharge records, cancer
registrations, and mortality records (Kendrick and Clarke, 1993).
These supplementary variables included the following: any
hospital admission with chronic obstructive pulmonary disease
(COPD) in the 10 years preceding diagnosis of breast/colorectal
cancer as a very crude proxy for smoking history; any hospital
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sadmission with alcohol-related diagnoses in the 10 years preceding
diagnosis of breast/colorectal cancer; the number of hospital
in-patient bed days in the period of 10 years up to 1 year preceding
diagnosis of breast/colorectal cancer (as a crude indicator of
general preexisting comorbidity); the number of emergency
admissions to hospital in the 30 days either before or after
diagnosis of breast/colorectal cancer; and place of death (from the
full mortality record) for deceased patients. The diagnostic codes
used to identify COPD and alcohol-related diagnoses are shown in
Appendix 1. On the basis of the postcode of residence at the time
of diagnosis, patients were assigned to a deprivation fifth using the
Scottish Index of Multiple Deprivation (Scottish Government,
2006). This has seven domains (income, employment, education,
housing, health, crime, and geographical access) at datazone level,
which have been combined into an overall index to identify area
concentrations of multiple deprivation.
Mode of presentation was investigated by examining the SCR
‘method of first detection’ variable, and the type of admission,
speciality, and main diagnosis leading to hospital admission in the
first hospital episode of the continuous in-patient stay, during
which time the cancer was first mentioned on a hospital discharge
record (restricted to admissions for the cancer occurring within 30
days of either side of the SCR incidence date).
The study population was divided into patients who died within
30 days of incidence/diagnosis (cases) and those who survived
beyond this threshold (controls). Follow-up was until the end of 2008.
For each characteristic examined, the w
2-test of association was
used to assess differences in proportions between cases and
controls. Logistic regression modelling was used to generate
adjusted odds ratios and their 95% confidence intervals. Cause of
death and place of death were not included as factors in the logistic
regression model because, by definition, the period of follow-up
differed between cases and controls.
RESULTS
The study included 36484 patients. The distribution of early
deaths, later deaths, and percentage of the cohort alive at the end
of follow-up according to cancer site is summarised in Table 1. The
proportion of early deaths was significantly higher in patients with
colorectal cancer (6.6%) compared with patients with breast cancer
(1.3%; Po0.001). The difference in the percentage of each cohort
alive at the end of follow-up (50.3% for colorectal cancer; 79.3% for
breast cancer) was also statistically significant (Po0.001).
Breast cancer
The distribution of characteristics of cases and controls is shown
in Table 2. On the basis of univariate analysis, patients dying
within 30 days of diagnosis were significantly more likely to be
elderly; to lie outside the least-deprived category; to spend more
time in hospital in the 10 years before diagnosis; to have been
previously admitted for COPD; to have had one or more
emergency admissions in the 30 days around diagnosis; to have
had their tumour diagnosed without histology; and to have
received no active treatment within 30 days of diagnosis. A lower
rate of microscopic verification resulted in higher proportions of
pathology-derived variables with unknown values among cases,
making interpretation difficult. However, there is some evidence
that cases were more likely to present with advanced disease, and
less likely to present with low-grade tumours or oestrogen
receptor-positive tumours. Just under 66% of cases had their
primary cause of death attributed to breast cancer, and just over
70% of cases died in hospital.
The results of logistic regression modelling are shown in Table 3.
Interactions were considered between age with other covariates,
and stage with other covariates, and only inclusion of an
interaction between age and the emergency admission variable
resulted in a better-fitting model. After adjustment for covariates,
the following factors remained predictive of death within 30 days
of diagnosis: age group, deprivation category, emergency admis-
sions, microscopic verification status, tumour stage, tumour grade,
and absence of any recorded treatment within 30 days of diagnosis.
Of the 249 patients dying within 30 days of diagnosis of breast
cancer, the ‘method of first detection’ was recorded as incidental
finding in 47 (18.9%) cases, clinical presentation with relevant
symptoms or signs in 153 (61.4%) cases, incidental finding at
autopsy, previously unsuspected in 6 (2.4%) cases, ‘other’ in 19
(7.6%) cases, and not known in 24 (9.6%) cases. No cases were
recorded as screen detected or interval cancers.
Only 155 (62.2%) cases and 11268 (58.8%) controls had a
hospital discharge record mentioning breast cancer with admis-
sion occurring within 30 days of the SCR incidence date. First
admission to these continuous in-patient stays was recorded as
emergency in 134 (86.5%) cases compared with 866 (7.7%)
controls. Only 44 (28.4%) of these 155 cases were first admitted
under general surgery, compared with 9916 (88%) of 11268
controls. A total of 87 (56.1%) cases were first admitted under
general medicine, a related subspeciality, or medicine for the
elderly. Breast cancer was recorded as the primary diagnosis (main
condition) in 91 (58.7%) cases compared with 10635 (94.4%)
controls.
Colorectal cancer
The distribution of characteristics of cases and controls is shown
in Table 4. On the basis of univariate analysis, patients dying
within 30 days of diagnosis were significantly more likely to be
elderly; to lie outside the least-deprived category; to have spent
more time in hospital in the 10 years before diagnosis; to have
been previously admitted for COPD; to have had previous alcohol-
related admissions; to have had one or more emergency
admissions in the 30 days around diagnosis; to have had their
tumour diagnosed without histology; and to have received no
active treatment within 30 days of diagnosis. As for breast cancer,
a lower rate of microscopic verification resulted in higher
proportions of pathology-derived variables with unknown values
among the cases, making interpretation difficult. However, there is
some evidence that cases were more likely to present with
advanced disease and possibly less likely to present with low-
grade tumours. Cases were less likely to have tumours of the
rectum or rectosigmoid, although around a quarter of them did
not have a tumour subsite specified. The male/female ratio was 1.2
among controls, but 1.0 among cases. Just under 73% of cases had
their primary cause of death attributed to colorectal cancer, and
just over 82% of cases died in hospital.
The results of logistic regression modelling are shown in Table 5.
Interactions were considered between age with other covariates
and Dukes’ stage with other covariates. Inclusion of interactions
for age and the emergency admission variable, age and micro-
scopic verification status, age and any treatment variable, and
Dukes’ stage and treatment resulted in a better-fitting model. After
adjustment for covariates, the following factors remained pre-
dictive of death within 30 days of diagnosis: age group, deprivation
category, previous in-patient bed days, previous admissions for
COPD, previous alcohol-related admissions, emergency admis-
sions, microscopic verification status, tumour subsite, Dukes’
stage, tumour grade, and treatment within 30 days of diagnosis.
The relationship between treatment and outcome was complex:
stage A, B, or C cases were more likely to have received treatment
within 30 days than were controls, whereas stage ‘D’ or unstaged
cases were less likely to have received treatment.
Of the 1129 patients dying within 30 days of diagnosis of
colorectal cancer, the ‘method of first detection’ was recorded as
screening examination in one (0.1%) case, incidental finding in 22
(1.9%) cases, clinical presentation with relevant symptoms or signs
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sin 937 (83.0%) cases, incidental finding at autopsy, previously
unsuspected in 20 (1.8%) cases, ‘other’ in 61 (5.4%) cases, and not
known in 88 (7.8%) cases. No cases were recorded as interval cancers.
Only 858 (76.0%) cases and 10609 (66.5%) controls had a
hospital discharge record mentioning colorectal cancer, with
admission occurring within 30 days of the SCR incidence date.
First admission to these continuous in-patient stays was recorded
as emergency in 685 (79.8%) cases compared with 3881 (36.6%)
controls. Only 495 (57.7%) of these 858 cases were first admitted
under general surgery, compared with 7536 (71.0%) of 10609
controls. A total of 276 (32.2%) cases were first admitted under
general medicine, a related subspeciality, or medicine for the
elderly. Colorectal cancer was recorded as the primary diagnosis
(main condition) in 620 (72.3%) cases compared with 9401
(88.6%) controls.
DISCUSSION
The main strengths of our study are the large number of patients
included (over 36000) and the availability of information for a
geographically defined population with universal health care and
complete coverage by cancer registration. The study should
include the same unselected spectrum of patients included in
successive iterations of the EUROCARE survival studies. Identify-
ing the population dying within 30 days is crucially dependent on
the definition of diagnosis or incidence date. Unlike many cancer
registries that choose from a hierarchy of dates dependent on the
timing of microscopic verification, the SCR applies a definition
published previously by the International Agency for Research on
Cancer (MacLennan, 1991). Essentially, this allocates the earliest
available date from a list of options, irrespective of microscopic
verification status. In practice, this is usually the date of first
relevant hospital contact for the cancer.
At first sight, the relatively low proportion of cases and controls
with relevant hospital discharge records occurring within 30 days
Table 1 Distribution of early deaths, later deaths, and percentage of the cohort alive at the end of follow-up, stratified by cancer site
Survived beyond 30 days
Cancer site All Died within 30 days % Total Alive Dead % of cohort alive at the end of 2008
Breast 19409 249 1.3 19160 15382 3778 79.3
Colorectal 17075 1129 6.6 15946 8582 7364 50.3
Table 2 Characteristics of patients dying within 30 days of diagnosis of
breast cancer in Scotland; period of diagnosis 2003–2007
Cases Controls
Characteristic Number % Number % P-value
Age group o0.001
o65 35 14.1 10676 55.7
65–74 49 19.7 4212 22.0
75–79 41 16.5 1614 8.4
80–84 48 19.3 1374 7.2
85+ 76 30.5 1284 6.7
SIMD fifth
a 0.013
1-Least deprived 28 11.2 3887 20.3
2 55 22.1 4008 20.9
3 60 24.1 4023 21.0
4 57 22.9 3880 20.3
5-Most deprived 49 19.7 3358 17.5
Previous inpatient bed days o0.001
0 111 44.6 7771 40.6
1–7 48 19.3 6431 33.6
8–28 40 16.1 3408 17.8
29+ 50 20.1 1550 8.1
Previous admission for COPD o0.001
Yes 19 7.6 462 2.4
No 230 92.4 18698 97.6
Previous alcohol-related admission 0.157
Yes 8 3.2 369 1.9
No 241 96.8 18791 98.1
Emergency admissions within 30 days of diagnosis date o0.001
0 77 30.9 17732 92.5
X1 172 69.1 1428 7.5
Microscopically verified o0.001
Yes 134 53.8 18943 98.9
No 103 41.4 196 1.0
Not known 12 4.8 21 0.1
Tumour stage o0.001
b
I 14 5.6 6710 35.0
II 10 4.0 7783 40.6
III 8 3.2 1506 7.9
IV 56 22.5 648 3.4
Not known 161 64.7 2513 13.1
Tumour grade o0.001
c
I 3 1.2 2343 12.2
II 23 9.2 7536 39.3
III 23 9.2 6441 33.6
Not known 200 80.3 2840 14.8
ER status o0.001
d
Positive 73 29.3 14668 76.6
Negative 22 8.8 3024 15.8
Not known 154 61.8 1468 7.7
Any treatment within 30 days of diagnosis o0.001
Yes 57 22.9 12880 67.2
No 192 77.1 6280 32.8
Table 2 (Continued)
Cases Controls
Characteristic Number % Number % P-value
Underlying cause of death 0.092
Breast cancer 163 65.5 2350 62.2
Other cancer 10 4.0 298 7.9
Diseases of circulatory system 40 16.1 572 15.1
Diseases of respiratory system 15 6.0 158 4.2
Any other cause 21 8.4 400 10.6
Place of death
e o0.001
NHS acute hospital 179 71.9 1951 51.8
Home 37 14.9 746 19.8
Hospice 7 2.8 477 12.7
Other institution 26 10.4 594 15.8
Abbreviations: COPD¼chronic obstructive pulmonary disease; ER¼oestrogen
receptor; SIMD¼Scottish index of multiple deprivation.
aSIMD not known for four
controls.
bPo0.001 excluding not known category.
cP¼0.222 excluding not known
category.
dP¼0.118 excluding not known category.
ePlace of death not known for 10
controls.
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sof the cancer registry incidence date seems surprising. However,
there are a number of potential explanations for this. For example,
in the case of elective referrals, the first relevant hospital contact
(and, therefore, the source of the cancer registry incidence date) is
likely to be an outpatient consultation – in some cases, the time to
in-patient admission may have exceeded 30 days. In some cases, if
patients are discharged from hospital before a pathology report is
issued, the definitive diagnosis of cancer may not be recorded. The
overall accuracy of main diagnosis on hospital discharge records is
estimated to be around 88% (Information Services Division, 2007);
it follows that the diagnosis will inevitably be misclassified and/or
miscoded in a proportion of cases.
The weaknesses of our study reflect the problems associated
with relying on routinely collected data: for example, problems of
attribution (of cause of death); problems of information complete-
ness (lack of information on stage or histological grade for some
tumours); and problems of surrogacy (the need to use diagnosis of
COPD as a proxy for smoking status, or the use of number of
hospital in-patient bed days as a proxy for comorbidity). In brief,
we have obtained statistical power and representativeness at the
expense of finer clinical details. The main weakness of our study is
the absence of information on any delays in presentation, referral,
Table 3 Results of multivariable logistic regression model for breast
cancer showing characteristics predictive of death within 30 days of
diagnosis
Characteristic
Odds
ratio
95% Confidence
interval P-value
Age group
o65 1.00
65–74 2.72 1.06 6.96 0.037
75–79 6.93 2.87 16.76 o0.001
80–84 6.34 2.52 15.98 o0.001
85+ 8.70 3.80 19.88 o0.001
SIMD fifth
1-Least deprived 1.00
2 1.47 0.86 2.51 0.154
3 1.96 1.15 3.31 0.013
4 1.17 0.69 1.99 0.563
5-Most deprived 1.05 0.61 1.80 0.861
Emergency admissions within
30 days of diagnosis date
0 1.00
X1 26.93 11.45 63.33 o0.001
Microscopically verified
Yes 1.00
No 6.76 4.64 9.83 o0.001
Not known 5.21 2.22 12.20 o0.001
Tumour stage
I 1.00
II 0.62 0.27 1.42 0.254
III 1.08 0.44 2.66 0.868
IV 5.28 2.74 10.17 o0.001
Not known 3.55 1.95 6.48 o0.001
Tumour grade
I–II 1.00
III 3.20 1.99 5.13 o0.001
Not known 3.20 1.99 5.13 o0.001
Any treatment within
30 days of diagnosis
Yes 1.00
No 4.20 3.01 5.86 o0.001
Abbreviation: SIMD¼Scottish index of multiple deprivation. The interaction term
age emergency admissions was included in the model.
Table 4 Characteristics of patients dying within 30 days of diagnosis of
colorectal cancer in Scotland; period of diagnosis 2003–2007
Cases Controls
Characteristic Number % Number % P-value
Age group o0.001
o65 131 11.6 4602 28.9
65–74 234 20.7 4884 30.6
75–79 220 19.5 2793 17.5
80–84 257 22.8 2138 13.4
85+ 287 25.4 1529 9.6
Sex 0.002
Male 564 50.0 8721 54.7
Female 565 50.0 7225 45.3
SIMD fifth
a o0.001
1-Least deprived 153 13.6 3046 19.1
2 210 18.6 3112 19.5
3 260 23.0 3347 21.0
4 264 23.4 3411 21.4
5-Most deprived 242 21.4 3029 19.0
Previous inpatient bed days o0.001
0 338 29.9 5488 34.4
1–7 257 22.8 5070 31.8
8–28 269 23.8 3512 22.0
29+ 265 23.5 1876 11.8
Previous admission for COPD o0.001
Yes 134 11.9 831 5.2
No 995 88.1 15115 94.8
Previous alcohol-related admission o0.001
Yes 83 7.4 598 3.8
No 1046 92.6 15348 96.2
Emergency admissions within 30 days of diagnosis date o0.001
0 212 18.8 10108 63.4
X1 917 81.2 5838 36.6
Microscopically verified o0.001
Yes 666 59.0 15028 94.2
No 441 39.1 856 5.4
Not known 22 1.9 62 0.4
Tumour sub-site o0.001
b
Proximal colon 323 28.6 4912 30.8
Distal colon 258 22.9 4213 26.4
Rectum/rectosigmoid 258 22.9 5533 34.7
Not known 290 25.7 1288 8.1
Dukes’ stage o0.001
c
A 17 1.5 1757 11.0
B 97 8.6 4176 26.2
C 127 11.2 3893 24.4
D 371 32.9 2709 17.0
Not known 517 45.8 3411 21.4
Tumour grade o0.001
d
I 8 0.7 411 2.6
II 264 23.4 8460 53.1
III 128 11.3 2186 13.7
IV 8 0.7 97 0.6
Not known 721 63.9 4792 30.1
Any treatment within 30 days of diagnosis o0.001
Yes 425 37.6 6876 43.1
No 704 62.4 9070 56.9
Underlying cause of death o0.001
Colorectal cancer 822 72.8 5678 77.1
Other cancer 59 5.2 468 6.4
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sor diagnosis, as well as direct information on lifestyle risk factors.
As a result, we are unable to determine whether patients dying
early have advanced disease because of delays in presentation,
referral, or diagnosis, or because of more aggressive disease, or
both, and if there seem to be any avoidable factors contributing to
their death. These questions can probably only be addressed by
further research involving review of medical records. Indeed, at
least some of the patients will already fall within the scope of the
existing and well-established Scottish Audit of Surgical Mortality
(Thompson and Stonebridge, 2005).
There are three main reasons for patients dying within a few
weeks of the diagnosis of cancer: advanced, biologically aggressive
disease by the time of diagnosis – death is directly due to the
cancer itself; death due to complications related to treatment of the
cancer – death is indirectly related to the cancer; and death due to
some coincidental cause – death is not related to the cancer, either
directly or indirectly. Any analysis of early deaths after the
diagnosis of cancer has specifically to consider which of these
reasons might apply. Earlier diagnosis of cancer might help
prevent deaths in the first and second categories but would be
unlikely to have any effect on the rate of intercurrent deaths.
Conversely, comorbidity would have an impact on the second and
third categories, but have limited impact on the first.
As expected, the overall mortality r a t ew a sh i g h e ri np a t i e n t sw i t h
colorectal cancer and the rate of early death was five times higher in
patients with colorectal cancer. These findings reflect the differences
i na n a t o m ya n dt h er o l eo fs u r g e r yi nt h et w od i f f e r e n tt y p e so f
tumour. Emergency surgery for breast cancer is an extreme rarity,
whereas 20% of operations for colorectal cancer are classed as urgent
or emergency procedures (Tekkis et al, 2003). Operative mortality is
much higher for colorectal cancer than it is for breast cancer –
around 5% for elective colorectal surgery, up to 20% for emergency
colorectal surgery (Tekkis et al, 2003), and less than 1% for breast
cancer surgery (El-Tamer et al, 2007). These factors will account for
the differences noted when Tables 2 and 4 are compared: only 23% of
patients with breast cancer who died within 30 days of diagnosis had
received any form of treatment for their tumour; the corresponding
figure for patients with colorectal cancer was 38%.
Unsurprisingly, multivariable analysis suggests that, compared
with patients surviving beyond 30 days, patients with breast cancer
dying early were more likely to be elderly; less likely to be affluent;
more likely to have been admitted as an emergency within 30 days
of diagnosis; less likely to have had their tumours microscopically
verified; more likely to have advanced disease (or stage not
known); more likely to have high-grade tumours (or grade not
known); and less likely to have had any treatment within 30 days of
diagnosis. Of the patients with breast cancer dying within 30 days,
just over 34% were recorded as having an underlying cause of
death other than breast cancer. Patients dying early from colorectal
cancer had similar characteristics but in addition were more likely
to have had a previous admission for COPD, and more likely to
Table 4 (Continued)
Cases Controls
Characteristic Number % Number % P-value
Diseases of circulatory system 114 10.1 678 9.2
Diseases of respiratory system 39 3.5 195 2.6
Any other cause 95 8.3 345 4.7
Place of death
e o0.001
NHS acute hospital 929 82.1 3691 50.2
Home 105 9.2 1895 25.8
Hospice 42 3.7 1233 16.8
Other institution 53 4.5 530 7.2
Abbreviations: COPD¼chronic obstructive pulmonary disease; SIMD¼Scottish
index of multiple deprivation.
aSIMD not known for one control.
bPo0.001 excluding
not known category.
cPo0.001 excluding not known category.
dPo0.001 excluding
not known category.
ePlace of death not known for 15 controls.
Table 5 Results of multivariable logistic regression model for colorectal
cancer showing characteristics predictive of death within 30 days of
diagnosis
Characteristic Odds ratio
95% Confidence
interval P-value
Age group
o65 1.00
65–74 2.50 1.28 4.89 0.007
75–79 5.41 2.76 10.60 o0.001
80–84 11.13 5.78 21.43 o0.001
85+ 15.92 8.15 31.07 o0.001
SIMD fifth
1-Least deprived 1.00
2 1.22 0.97 1.55 0.095
3 1.43 1.14 1.79 0.002
4 1.34 1.07 1.69 0.01
5-Most deprived 1.16 0.92 1.46 0.204
Previous inpatient bed days
0 1.00
1–7 0.81 0.67 0.98 0.026
8–28 0.87 0.72 1.05 0.135
29+ 0.96 0.78 1.17 0.669
Previous admission for COPD
No 1.00
Yes 1.46 1.17 1.84 0.001
Previous alcohol-related admission
No 1.00
Yes 1.59 1.19 2.12 0.002
Emergency admissions within
30 days of diagnosis date
0 1.00
X1 9.41 5.45 16.25 o0.001
Microscopically verified
Yes 1.00
No 8.43 4.92 14.45 o0.001
Not known 3.27 0.81 13.13 0.095
Tumour sub-site
Proximal colon 1.00
Distal colon 1.25 1.04 1.50 0.02
Rectum/rectosigmoid 1.11 0.92 1.35 0.272
Not known 2.19 1.80 2.67 o0.001
Dukes’ stage
A or B 1.00
C 1.48 1.12 1.94 0.006
D 1.71 1.26 2.32 0.001
Not known 1.35 0.98 1.84 0.064
Tumour grade
I–II 1.00
III–IV 1.50 1.20 1.88 o0.001
Not known 1.48 1.22 1.79 o0.001
Any treatment within
30 days of diagnosis
Yes 1.00
No 0.17 0.08 0.38 o0.001
Abbreviations: COPD¼chronic obstructive pulmonary disease; SIMD¼Scottish
index of multiple deprivation. Interaction terms age emergency admissions,
age microscopic verification, age any treatment, and Dukes’ stage any treat-
ment were included in the model.
Early deaths after breast or colorectal cancer in Scotland
DH Brewster et al
64
British Journal of Cancer (2011) 104(1), 60–67 & 2011 Cancer Research UK
C
l
i
n
i
c
a
l
S
t
u
d
i
e
shave had a previous alcohol-related admission. In contrast to
patients with breast cancer, they were more likely to have had
treatment within 30 days of diagnosis, at least for disease stages
A–C, perhaps reflecting the fact that they had presented acutely
with complications of their tumour, such as obstruction or
peritonitis, and required urgent surgery. However, it may be unwise
to draw definite conclusions about the relationship between
treatment and outcome from these observational data. Of the
patients with colorectal cancer dying within 30 days, just over 27%
were recorded as having an underlying cause of death other than
colorectal cancer. Patients dying early after a diagnosis of breast or
colorectal cancer were less likely to follow a conventional pathway to
diagnosis – for example, their first relevant admission to hospital
was less likely to be under the care of a surgeon.
Our ‘control’ group included some patients who will have
survived just a few days longer than our ‘cases’. Had we been able
to compare the characteristics of patients dying early with a
selected group of longer-term survivors, the differences that we
observed would most likely have been accentuated considerably.
The limited impact of socioeconomic position on early deaths
was unexpected, but may reflect limitations of the area-based
Scottish Index of Multiple Deprivation as an indicator of individual
status, and the fact that a high proportion of early deaths occurred in
the very elderly, in an age range less commonly attained by people
from deprived communities in which life expectancy is lower than
average. Similarly, failure to show a clear effect of previous in-patient
bed days may reflect better-than-average health of individuals who
survive beyond the age of 85 years, as well as inclusion of related
covariates, such as previous admissions for COPD, previous alcohol-
related admissions, and emergency admissions in the model.
There is certainly evidence from other studies that some patients
present themselves for the first time many weeks or months after
the onset of relevant symptoms, and some of the reasons for
prehospital delays have been identified (Macleod et al, 2009).
Awareness of cancer warning signs appears to be low in Britain,
particularly in those who are males, younger, and from lower
socioeconomic status groups or ethnic minorities, and there are a
number of perceived barriers for consulting (Robb et al, 2009).
There is some amount of evidence that interventions delivered to
individuals may increase cancer awareness and that interventions
delivered to communities may promote awareness and early
presentation (Austoker et al, 2009). However, it is of course also
important to monitor potential adverse effects of any interven-
tions, such as overwhelming diagnostic services.
At the same time, evidence that delays are associated with more
advanced disease stage or lower survival is inconsistent and
sometimes counterintuitive. It seems that some patients with
aggressive, poor prognosis disease are more likely to present
quickly and to be fast-tracked by health services. In fact, the
paradox of patients with prolonged duration of symptoms, but
who have a better prognosis than patients with shorter duration of
symptomatic disease, was highlighted many years ago (Feinstein,
1964). Even then, it was recognised that some patients with longer
clinical histories probably had tumours that were biologically less
aggressive.
Unfortunately, studies on the impact of delay on outcome suffer
from a number of limitations, including differing definitions of
delays, differing ways of measuring delays, failure to take account of
aggressiveness of tumours, failure to allow for emergency admissions
(particularly relevant for colon cancer), and failure to take account of
lead-time bias (Neal, 2009). Thus, although there may be inevitability
about presentation with advanced disease for some individuals, this
should not be used to defend avoidable delays faced by other patients
living with the anxiety that they may (or do) have cancer.
One further avenue of research that might yield insights is the
impact of lifestyle factors on survival from (as opposed to risk of)
cancer. The calculation of relative survival can allow for competing
causes of death associated with lifestyle factors, but cannot adjust
fully for direct effects of these factors on cancer prognosis. For
some cancers, there is evidence that smoking is associated with
more advanced stage of disease at diagnosis, although it is not
clear whether this reflects a difference in health-seeking behaviour
or a direct effect of tobacco on tumour biology (Longnecker et al,
1989; Kobrinsky et al, 2003). Furthermore, there is evidence that
smoking and some other lifestyle factors reduce the effectiveness
of a range of treatments, including surgery, radiotherapy, and
chemotherapy (Gritz et al, 2005; Gritz and Demark-Wahnefried,
2009), and smoking has been shown to have an independently
adverse impact on cause-specific survival in patients who have had
resections for colorectal cancer (Munro et al, 2006). We have been
unable to find data on the prevalence of continuous active smoking
among patients with cancer in different countries; however,
whereas estimates of overall adult smoking prevalence are
considerably lower in Sweden than in Scotland (Scottish Public
Health Observatory, 2010), estimates for other Nordic countries
are more similar to Scotland, suggesting that smoking is unlikely
to be the sole explanation for the reported survival deficit in
Scotland. For operable patients, there is evidence that both
smoking and alcohol abuse increase the risk of postoperative
complications, and there is also some evidence that intensive
presurgical interventions aimed at addressing these risk factors
can improve outcomes (Tønnesen et al, 2009). Obesity and lack of
physical activity also seem likely to increase the risks associated
with surgery and tackling these problems in the interval between
diagnosis and surgery might have a role in reducing the risk of
early death. There is also emerging evidence that personality type,
mental well-being, and resilience may influence outcomes, and
these factors may also be important influences on early mortality
(Aspinwall and MacNamara, 2005; Mackenbach, 2010).
In conclusion, we have shown that patients dying within 30 days
of a diagnosis of breast or colorectal cancer have many
unfavourable prognostic characteristics. Further research is
required to determine the mechanisms through which these effects
are mediated and, more particularly, whether interventions aimed
at dealing with them can improve survival.
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Appendix 1. Diagnostic codes used to identify hospital admissions with chronic obstructive pulmonary disease (COPD)
and alcohol-related diagnoses
ICD-9 code ICD-10 code Condition
COPD
490 J40 Bronchitis, not specified as acute or chronic
J41 Simple and mucopurulent chronic bronchitis
491 J42 Unspecified chronic bronchitis
492 J43 Emphysema
496 J44 Other COPD
Alcohol-related diagnoses
E244 Alcohol-induced Pseudo-Cushing’s syndrome
E512 Wernicke0s encephalopathy
291 F10 Mental and behavioural disorders due to use of alcohol
303
G312 Degeneration of nervous system due to alcohol
3575 G621 Alcoholic polyneuropathy
G721 Alcoholic myopathy
4255 I426 Alcoholic cardiomyopathy
5353 K292 Alcoholic gastritis
5710 K70 Alcoholic liver disease
5711
5712
5713
K860 Alcohol-induced chronic pancreatitis
O354 Maternal care for (suspected) damage to fetus from alcohol
7903 R780 Finding of alcohol in blood
9800 T510 Toxic effect of ethanol
9801 T511 Toxic effect of methanol
3050 T519 Toxic effect of alcohol, unspecified
9809
E860 X45 Accidental poisoning by and exposure to alcohol
X65 Intentional self-poisoning by and exposure to alcohol
Y15 Poisoning by and exposure to alcohol undetermined intent
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sE9473 Y573 Alcohol deterrents
Y90 Evidence of alcohol involvement determined by blood alcohol level
Y91 Evidence of alcohol involvement determined by level of intoxication
Z502 Alcohol rehabilitation
Z714 Alcohol abuse counselling and surveillance
Z721 Alcohol use
Appendix 1. (Continued)
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